Back
Amarin Corp PLC 10K Form
Sell
35
AMRN
Amarin Corp PLC
Last Price:
0.55
Seasonality Move:
7.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | AMRN/Amarin Corp PLC Quarterly |
| 2023-11-01 | 10Q | AMRN/Amarin Corp PLC Quarterly |
| 2023-08-02 | 10Q | AMRN/Amarin Corp PLC Quarterly |
| 2023-05-03 | 10Q | AMRN/Amarin Corp PLC Quarterly |
| 2022-10-27 | 10Q | AMRN/Amarin Corp PLC Quarterly |
| 2022-08-03 | 10Q | AMRN/Amarin Corp PLC Quarterly |
Receive AMRN News And Ratings
See the #1 stock for the next 7 days that we like better than AMRN
AMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $306.91M |
|---|---|
| Cash Flow: | $-2.36M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.29 |
| Price / Book: | 0.41 |
Profitability
| EPS (TTM): | -0.09630 |
|---|---|
| Net Income (TTM): | $-39.35M |
| Gross Margin: | $165.54M |
| Return on Equity: | -7.2% |
| Return on Assets: | -4.91% |
Amarin Corp PLC Earnings Forecast
Key Amarin Corp PLC Financial Ratios
- The Gross Profit Margin over the past 31 years for AMRN is 53.94%.
- The Selling, General & Administrative Expenses for AMRN have been equal to 65.15% of Gross Profit Margin.
- The Research & Development expenses have been 7.24% of Revenue.
- The Interest Expense is -0.01% of Operating Income.
- The Net Earning history of AMRN is -19.26% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 17 years.
Amarin Corp PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMRN |
| CUSIP: | 023111 |
| Website: | amarincorp.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.23 |
| Quick Ratio: | 2.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AMRN Technical Analysis vs Fundamental Analysis
Sell
35
Amarin Corp PLC (AMRN)
is a Sell
Is Amarin Corp PLC a Buy or a Sell?
-
Amarin Corp PLC stock is rated a Sell
The current Amarin Corp PLC [AMRN] share price is $0.52. The Score for AMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.